Background/Aim: Genetic analysis in neuroblastoma has identified the profound influence of MYCN amplification and 11q deletion in patients ’ prognosis. These two features of high-risk neuroblastoma usually occur as mutually exclusive genetic markers, although in rare cases both are present in the same tumor. The purpose of this study was to characterize the genetic profile of these uncommon neuroblastomas harboring both these high-risk features. Methods: We selected 18 neuroblastomas with MNA plus 11q loss detected by FISH. Chromosomal aberrations were analyzed using Multiplex Ligation-dependent Probe Amplification and Single Nucleotide Polymorphism array techniques. Results and Conclusion: This group of tumors has approximately the same hi...
Neuroblastoma is an aggressive embryonal tumor that accounts for ~15% of childhood cancer deaths. Hi...
MYCN amplification and 11q deletion are two inversely correlated prognostic factors of poor outcome ...
Neuroblastoma is an aggressive embryonal tumor that accounts for similar to 15% of childhood cancer ...
<div><h3>Background/Aim</h3><p>Genetic analysis in neuroblastoma has identified the profound influen...
We have studied the occurrence and association of 11q deletions with other chromosomal imbalances in...
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and t...
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and t...
Background. Neuroblastomas are characterized by chromosomal alterations with biological and clinical...
BACKGROUND: Neuroblastomas are characterized by chromosomal alterations with biological and clinical...
Neuroblastomas are characterized by chromosomal alterations with biological and clinical significanc...
Background: Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system and the most frequent...
Neuroblastomas are characterized by chromosomal alterations with biological and clinical significanc...
Neuroblastomas are characterized by chromosomal alterations with biological and clinical significanc...
Background: Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system and the most frequent...
Neuroblastoma is a very heterogeneous tumor, with a clinical course ranging from spontaneous regress...
Neuroblastoma is an aggressive embryonal tumor that accounts for ~15% of childhood cancer deaths. Hi...
MYCN amplification and 11q deletion are two inversely correlated prognostic factors of poor outcome ...
Neuroblastoma is an aggressive embryonal tumor that accounts for similar to 15% of childhood cancer ...
<div><h3>Background/Aim</h3><p>Genetic analysis in neuroblastoma has identified the profound influen...
We have studied the occurrence and association of 11q deletions with other chromosomal imbalances in...
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and t...
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and t...
Background. Neuroblastomas are characterized by chromosomal alterations with biological and clinical...
BACKGROUND: Neuroblastomas are characterized by chromosomal alterations with biological and clinical...
Neuroblastomas are characterized by chromosomal alterations with biological and clinical significanc...
Background: Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system and the most frequent...
Neuroblastomas are characterized by chromosomal alterations with biological and clinical significanc...
Neuroblastomas are characterized by chromosomal alterations with biological and clinical significanc...
Background: Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system and the most frequent...
Neuroblastoma is a very heterogeneous tumor, with a clinical course ranging from spontaneous regress...
Neuroblastoma is an aggressive embryonal tumor that accounts for ~15% of childhood cancer deaths. Hi...
MYCN amplification and 11q deletion are two inversely correlated prognostic factors of poor outcome ...
Neuroblastoma is an aggressive embryonal tumor that accounts for similar to 15% of childhood cancer ...